Skip to content
Home/Companies/Pharma/Dechra Pharmaceuticals

Dechra Pharmaceuticals

Pharma·United Kingdom·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Dechra Pharmaceuticals?

Dechra Pharmaceuticals is a British Pharma company, currently owned by EQT since 2024.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
EQT
Investor
EQT
EQT X · 2023 · Buyout

Key facts

HQUnited Kingdom
SectorPharma
StatusActive

More from EQT X

Other portfolio companies in the same fund.

Coches.net
Active
E-commerceSpain· 2026
InfoJobs
Active
HR TechSpain· 2026
Mews
Mews
Active
SaaSNetherlands· 2026
Europa Biosite
Active
HealthcareSweden· 2025
Fortnox
Fortnox
Active
SaaSSweden· 2025
OEM International
Active
IndustrialsSweden· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Dechra Pharmaceuticals?

Dechra Pharmaceuticals is currently owned by EQT, through EQT X, since 2024.

When did EQT acquire Dechra Pharmaceuticals?

EQT acquired Dechra Pharmaceuticals in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue